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Purpose: To compare the diagnostic accuracies of diffu-
sion-weighted imaging (DWI), T2-weighted imaging (T2WI),
and the combination of both sequences in discriminating
benign from malignant focal liver lesions (FLLs).
Materials and Methods: In all, 166 patients with 269 FLLs
(153 benign and 116 malignant) were retrospectively eval-
uated. Two abdominal readers visually assessed the DWI,
T2WI, and the combined (DWIþT2WI) image sets in an inde-
pendent and blinded manner. The diagnostic abilities of
each image set in discriminating the benign from the
malignant FLLs set were compared using a binary logistic
regression model. Pathologic results, consensus reading,
and follow-up imagingwere used as the reference standard.
Results: The overall characterization accuracy in all
lesions of the combined set (80.3%) was significantly
higher than those of the T2WI set (68.8%) and DWI set
(73.2%) (combined vs. T2WI, P < 0.001; combined vs.
DWI, P ¼ 0.001), while there was no significant difference
between the T2WI and DWI sets (P ¼ 0.058). All image
sets were more accurate in the characterization of malig-
nant FLLs than of benign FLLs (P < 0.001).
Conclusion: T2WI and DWI are complementary in dis-
criminating benign from malignant FLLs; their combina-
tion improves diagnostic confidence.
Key Words: diffusion-weighted imaging; T2-weighted
imaging; focal liver lesions
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MAGNETIC RESONANCE IMAGING (MRI) yields excel-
lent tissue contrast through a wide range of pulse
sequences and can visualize the internal structures
and several functional processes in the body. Beyond
controversy, dynamic enhanced MRI with several con-
trast agents has a major role in the detection and
characterization of focal liver lesions (FLLs). However,
unenhanced MR sequences such as T2-weighted
imaging (T2WI) and diffusion-weighted imaging (DWI)
could provide additional important information for the
differential diagnosis of FLLs and they cannot be
omitted from a state-of-the-art MR liver protocol. Fur-
thermore, in those patients with contraindications to
contrast agents, the unenhanced MR sequences
become crucial in the characterization of FLLs. Classi-
cally, T2WI is considered a useful sequence for
discriminating benign cystic lesions (eg, simple cyst,
hemangioma, etc) from malignant solid lesion (eg,
metastasis, hepatocellular carcinoma [HCC], etc) on
the basis of the degree of the signal intensity of the
lesion, but its utility in the differentiation between
solid benign and malignant lesions may be limited.
DWI is another useful sequence, which provides tis-
sue contrast based on the diffusion properties of
water molecules in tissue, without using any contrast
agents. Based on a series of recent advances in MRI,
including high-performance gradient systems, single-
shot echo-planar imaging (EPI), and parallel acquisi-
tion techniques (eg, sensitivity encoding: SENSE),
abdominal DWI is increasingly being applied for lesion
detection and characterization (1–12), monitoring and
predicting treatment response (13–16), and assess-
ment of chronic liver disease (17,18). DWI not only is
able to provide a high lesion-to-background contrast
compared to other unenhanced MR sequences
(7,9,11,12), it also provides (quantitative) physiologi-
cal information by means of apparent diffusion coeffi-
cient (ADC) measurements. ADCs are, among others,
thought to reflect tissue cellularity and cell membrane
integrity, and may aid in lesion characterization. In
the past decade, several researchers indicated the
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utility of abdominal DWI in the differentiation of FLLs,
although overlaps in ADCs are observed between
some benign and malignant tumors (1–11). The rela-
tively low spatial resolution and the signal loss in the
left hepatic lobe due to cardiac pulsation are some of
the limitations of DWI. Therefore, DWI has not yet
replaced T2WI in routine protocols because it simulta-
neously has several intrinsic advantages and realistic
limitations. Until now, there have only been a few
comparative investigations between T2WI and DWI in
the characterization of FLLs (11,19), and those stud-
ies (11,19) did not include a large number and wide
spectrum of FLLs, in particular solid benign tumors
(eg, focal nodular hyperplasia [FNH] and adenoma).
Furthermore, to our knowledge, there is no published
study that investigated the diagnostic ability of the
combined interpretation of both sequences compared
to each sequence alone.
The purpose of this study was therefore to compare
the diagnostic accuracies of DWI alone, T2WI alone,
and a combined interpretation of the two sequences for
discriminating benign from malignant FLLs, in a large
number of patients with a wide spectrum of FLLs.
MATERIALS AND METHODS
Our Institutional Review Board approved this retro-
spective study. Written informed consent from
patients was waived. All data and information derived
from and pertaining to the study were under the
exclusive control of the investigating radiologists.
Patients
We retrospectively reviewed our hospital reporting
database of MR examinations (including DWI) for
patients suspected of having FLLs for the period
between June 2008 and February 2010. A total of
348 patients who were suspected of having FLLs were
identified. Among these patients, 182 patients were
excluded because of 1) having no FLL (n ¼ 92); 2) only
having FLLs with a maximum diameter of less than 5
mm (as measured on dynamic contrast-enhanced
images, including hepatobiliary phase images, with
conventional gadolinium chelates or hepatocyte-spe-
cific agents [eg, Gd-BOPTA or Gd-EOB-DTPA]) in
which unfavorable partial volume effects frequently
occur (n ¼ 31); 3) clinical and imaging follow-up of
less than 6 months (n ¼ 36); 4) regional therapy
(transarterial chemoembolization, radiofrequency
ablation, or percutaneous ethanol injection) or sys-
temic chemotherapy before MRI, which could affect
signal of the lesions at DWI (n ¼ 23).
Hence, a total of 166 patients (76 men, 90 women;
mean age [6 standard deviation], 56.0 6 16.1 years;
age range, 12–87 years) with 269 FLLs (lesions with a
maximum diameter of less than 5 mm were excluded)
were enrolled in this study (Table 1).
There were 42 patients with chronic liver disease,
including 10 with chronic hepatitis and 31 with liver
cirrhosis related to viral hepatitis B (n ¼ 15), viral
hepatitis C (n ¼ 20), viral hepatitis B and C (n ¼ 1), or
alcohol abuse (n ¼ 6). There were six patients with
steatosis and 119 patients with a normal background
liver parenchyma.
The metastases in the 18 patients with metastatic
liver disease originated from colon (n ¼ 10), breast
(n ¼ 3), kidney (n ¼ 2), stomach (n ¼ 1), and pancreas
cancer (n ¼ 1), and a gastrointestinal tumor (n ¼ 1).
Multiple lesions (range, 2–5 lesions) were noted in 45
of the 166 patients and different histologic types of
lesions (eg, HCC and hemangioma) coexisted in 23
patients.
FLLs and Standard of Reference
The final diagnosis of each FLL was based on patho-
logic results, consensus reading by two qualified
abdominal radiologists with more than 10 years of
experience using precontrast and dynamic contrast-
enhanced MR images, clinical information, and/or
follow-up imaging evaluations. Finally, 269 FLLs (153
benign and 116 malignant lesions) with an average di-
ameter of 30.4 6 22.0 mm (range, 6–150 mm) were
confirmed through this process. The 153 benign
lesions consisted of 51 hemangiomas, 28 cysts, 54
FNHs, 17 adenomas, two pseudotumors, and one
abscess, while the 116 malignant lesions consisted of
34 metastases, 55 HCCs, 22 cholangiocarcinomas
(CCCs), and five lymphomas (Table 1). In all, 100 of
269 FLLs were located in the left lobe (S1–4) and the
remaining 169 were located in the right lobe (S5–8).
Among 153 benign lesions, 32 lesions were diag-
nosed histopathologically: all 17 adenomas (five by
Table 1
Clinical Information of the 166 Patients and Characteristics of 269
Focal Liver Lesions
Age range (mean age) 12-87 years (56.0 years)
Sex (M/F) 76/90
Diagnosis of the
lesions (n ¼ 269)
Benign (n ¼ 153) 51 hemangioma
54 FNH
17 adenoma
28 cyst
2 pseudotumor
1 abscess
Malignant (n ¼ 116) 55 HCC
34 metastasis
22 CCC
5 lymphoma
Location of the lesions 100 right lobe 169 left lobe
Background liver 10 chronic hepatitis
31 liver cirrhosis
6 steatosis
119 normal liver
Primary site of metastatic
patients (n ¼ 18)
10 colon
3 breast
2 kidney
1 stomach
1 pancreas
1 gastrointestinal tumor
FNH: focal nodular hyperplasia; HCC: hepatocellular carcinoma;
CCC: cholangiocellular carcinoma; LC: liver cirrhosis.
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resection and 12 by biopsy), 11 FNHs (all by biopsy),
three hemangiomas (all by biopsy) and one abscess
(by fluid drainage). In the remaining 119 lesions,
except for the two pseudotumors (47 hemangiomas,
44 FNHs, and all 28 cysts), the diagnosis was
established based on laboratory findings, established
characteristic imaging criteria (20–23), and their sta-
ble appearance in size at follow-up imaging studies.
The existence of two pseudotumors in one patient was
confirmed based on a decrease in their size on serial
follow-up imaging evaluations. In 42.6% (23/54) of
FNHs a central scar was identified within the mass on
dynamic contrast-enhanced MR images.
Among 116 malignant lesions, 76 lesions were diag-
nosed histopathologically: 34 HCCs (11 by resection
and 23 by biopsy), 19 CCCs (seven by resection and
12 by biopsy), 18 metastases (all by biopsy), and all
five lymphomas (two by resection and three by
biopsy). The 21 HCCs in 14 cirrhotic patients and the
three CCCs in two patients (who did not have any
other extrahepatic malignant lesions, which may have
caused hepatic metastasis) were diagnosed by charac-
teristic imaging findings (23–27), including the Ameri-
can Association for the Study of Liver Disease
(AASLD) criteria for HCC (28) and elevated tumor
markers (eg, a-fetoprotein and plasma prothrombin in
vitamin K absence for HCC, and carbohydrate antigen
19-9 for CCC). The diagnosis of 16 metastases was
based on follow-up imaging studies (range, 94–158
days), which showed size progression.
MRI
MRI was performed using a 1.5-T scanner with an
18-channel system (Avanto, Siemens Medical Systems,
Erlangen, Germany) equipped with high-performance
gradients (maximum gradient strength of 45 mT/m;
peak slew rate of 200 mT/m/ms) and a 12-element
(dorsoabdominal two six-element) surface phased-
array coil in all patients.
Before administration of contrast agent, a breath-
hold dual-echo T1-weighted gradient-dual echo
sequence, a navigator-triggered T2-weighted turbo
spin-echo (TSE) sequence with and without fat-sup-
pression, and a navigator-triggered DWI were obtained
in transverse directions as precontrast images. After
scanning these precontrast images, fat-saturated
dynamic contrast-enhanced 3D gradient-echo sequen-
ces with volumetric interpolated breath-hold examina-
tion image (VIBE; Siemens) were performed.
Integrated parallel imaging techniques (iPAT) using
generalized autocalibrating partially parallel acquisi-
tion (GRAPPA) with an acceleration factor of two were
applied to all sequences to shorten the echo train
length (ETL) in order to improve image quality and
reduce acquisition time.
For respiratory triggering, we used the prospective
acquisition correction (PACE; Siemens Medical Solu-
tions), which measures the temporal position of the
diaphragm during free breathing.
The PACE technique and a single-shot spin-echo
EPI sequence, accommodating four motion probing
gradients, were applied for navigator-trigged DWI.
Navigator-trigged DWI was performed with the follow-
ing parameters: TR/TE, 2000/71 msec; echo train
length, 77; bandwidth, 1628 Hx/pixel; field of view
(FOV), 320–450 mm; spectral attenuated inversion
recovery (SPAIR); matrix size, 77  192; number of
signal averages, 3; section thickness/gap, 6/1 mm;
28–38 sections; acquisition time, 4–5 minutes.
Tridirectional motion probing gradients with different
b-values (50, 400, and 800 s/mm2) were applied in
one acquisition. The diffusion-weighted images with a
low b-value (50 s/mm2) served as a black blood image
with high signal-to-noise ratio.
Respiratory-triggered T2-weighted TSE sequences
with and without fat-suppression were obtained with
the following parameters: TR/TE, 2120/79 msec;
ETL, 14; flip angle, 150, section thickness/gap, 6/1
mm; 28–38 sections; FOV, 380–500 mm; matrix size,
81  320; number of signal averages, 1; acquisition
time, 3–5 minutes.
Imaging Analysis
All MR images were independently interpreted by two
abdominal radiologists who were blinded to all clinical
information, including MRI reports, clinical history,
pathologic findings, and other MR sequences (eg,
dynamic contrast-enhanced MRI) using a local picture
archiving and communication system monitor (iSite
Radiology, Philips Healthcare, Best, Netherlands). The
two readers evaluated three image datasets: 1) DWI
alone; 2) T2WI (with and without fat-suppression)
alone; and 3) the combination of both (DWI and
T2WI), with a 1-month interval between the evaluation
of different image sets. Before each reading session,
the two readers were trained using some representa-
tive cases (which were not included in this analysis)
in order to become familiar with the predefined imag-
ing criteria for FLL characterization at DWI and T2WI.
Based on lesion morphology and degree and homo-
geneity of lesion signal on each image, the readers
categorized all lesions as benign or malignant using
the following three-point grading scale: 1 ¼ benign; 2
¼ indeterminate; 3 ¼ malignant, as some authors
adopted in recent articles (11). For the evaluation of
DWI, both the images obtained with three different
b-values (50, 400, and 800 s/mm2) and the ADC maps
were assessed and the following criteria were used
(2,3,6,11) (Fig. 1): a lesion was regarded as benign, if
the lesion was hyperintense at DWI obtained with a
b-value of 50 s/mm2, showing signal intensity decrease
with increasing b-values, and exhibited subjectively
hyperintensity to the surrounding liver parenchyma on
ADC maps. A lesion was regarded as malignant if the
lesion was hyperintense at DWI obtained with a b-value
of 50 s/mm2 and the signal remained hyperintense at
DWI obtained with a b-value of 800 s/mm2, and exhib-
ited hypointensity relative to the surrounding liver
parenchyma on ADC maps. A lesion was regarded as
indeterminate if the lesion did not fulfill either of these
imaging criteria.
For the evaluation of T2-weighted images, the fol-
lowing criteria were used (29–31) (Fig. 1): a lesion was
regarded as benign if the lesion showed a well-defined
T2WI DWI Combined FLLs 3
margin and homogeneous marked hyperintensity rela-
tive to the surrounding liver parenchyma. A lesion
was regarded as malignant if the lesion showed
ill-defined margins and heterogeneous mild to moder-
ate hyperintensity relative to the surrounding liver
parenchyma. A lesion was regarded as indeterminate
if the lesion did not fulfill either of these imaging
criteria (eg, a lesion showing isointensity relative to
the surrounding liver parenchyma). Based on these
criteria, the readers classified all lesions into three
categories (benign, indeterminate, and malignant) at
DWI and T2WI separately. In the combined reading
session, the reader classified all lesions using both
criteria for DWI and T2WI at their discretion.
Statistical Analysis
The diagnostic efficacies of T2WI alone, DWI alone,
and the combination of both sequences for visual dis-
crimination between benign and malignant liver
lesions were evaluated. A lesion characterization iden-
tical to the definitive diagnosis (benign or malignant)
was defined as a correct diagnosis, whereas a charac-
terization not identical to the definitive diagnosis or
characterization as indeterminate was defined as an
incorrect diagnosis. A statistical analysis was done by
using a binary logistic regression model in which the
diagnostic accuracy was included as a dependent
variable.
Figure 1. Metastasis from colon cancer and small cysts in a 67-year-old man. Transverse T2-weighted image (b–d). Trans-
verse DWIs obtained with b-values of 50 (b), 400 (c), and 800 (d) s/mm2, (e) ADC map. At T2WI (a), metastasis (solid arrow)
in segment VI is moderately hyperintense and a small cyst (dotted arrow) in segment III shows marked hyperintensity relative
to surrounding liver parenchyma. On navigator-triggered DWIs (b–d), the metastasis with restricted diffusion is moderately
hyperintense at a b-value of 50 s/mm2 and the signal is largely retained at a b-value of 800 s/mm2, which is compatible
with a malignant lesion. On the other hand, the small cyst containing free water is markedly hyperintense at a b-value of
50 s/mm2 and the signal completely disappears at a b-value of 800 s/mm2, which is a typical feature of a benign lesion. On
the ADC map (e), the metastasis is hypointense (solid arrow), which corresponds to a low ADC (0.89  103mm2/s) and the
small cyst shows distinct hyperintensity (dotted arrow) with a high ADC (2.97  103mm2/s) relative to the surrounding liver
parenchyma.
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In consideration of a potential lesion correlation
within the same patient, the analysis was performed
using a generalized linear mixed model including
patient and lesion as random effects and MR
sequence (T2WI vs. DWI vs. T2WIþDWI), reader
(reader 1 vs. reader 2), and definitive diagnosis (be-
nign vs. malignant) as fixed effects. An interaction
between readers and diagnostic imaging modalities
was also included in the model.
Similar analyses were also performed in subgroups
according to the definitive diagnosis (benign or malig-
nant lesions). In these subgroup analyses the defini-
tive diagnosis was excluded from the model. We eval-
uated the diagnostic capabilities using an adjusted
odds ratio (OR) and a P value. A P value of less than
0.05 was considered significant. Reader agreement at
T2WI and DWI was analyzed using the weighted k sta-
tistic, defined as poor (<0.2), fair (>0.2 to 0.4), mod-
erate (>0.4 to 0.6), good (>0.6 to 0.8), and excel-
lent (>0.8 to 1) agreement. All analyses were
performed using commercial statistical software (SAS,
v. 9.0 and JMP, v. 8; SAS Institute Japan, Tokyo,
Japan).
RESULTS
Visual Assessment
Correctly characterized FLLs using the different sequen-
ces (T2WI and DWI) and their combination in all,
benign, and malignant lesions are shown in Table 2.
The overall characterization accuracies in all lesions
with T2WI, DWI, and the combined (T2WIþDWI) sets
were 68.0%, 73.2%, and 80.3%, respectively. There
was a significant difference between T2WI and the
combined set (adjusted OR, 8.457, P < 0.001) and
between DWI and the combined sets (adjusted OR,
4.268, P ¼ 0.001).
Meanwhile, no significant difference was observed
in the characterization accuracy between the T2WI
and DWI sets (adjusted OR, 1.984, P ¼ 0.058).
All image sets were more accurate in the characteri-
zation of malignant FLLs than of benign FLLs
(adjusted OR, 68.204, P < 0.001).
The correctly characterized FLLs using the different
sequences (T2WI and DWI) and their combination by
each reader in all, benign, and malignant lesions are
shown in Table 3. The subgroup analysis in the benign
lesions showed no significant interaction between read-
ers on each MR sequence. In a comparison of all
sequences in the benign lesions, the characterization
accuracies with T2WI, DWI, and the combined sets
were 50.3%, 64.7%, and 67.0%, respectively, showing
a significant difference between DWI and T2WI sets
and between the combined and T2WI sets (DWI vs.
T2WI: adjusted OR, 34.679, P < 0.001; the combined
vs. T2WI: adjusted OR, 48.285, P < 0.001). In the char-
acterization accuracy of the benign lesions, no signifi-
cant difference was observed between DWI and the
combined sets (adjusted OR, 1.500, P ¼ 0.504).
The subgroup analysis in the malignant lesions
showed a significant effect of the readers on characteri-
zation accuracy. The characterization accuracy of
reader 2 was significantly lower than that of reader 1
(adjusted OR, 0.200, P ¼ 0.045). In a comparison of all
sequences in the malignant lesions, the characteriza-
tion accuracies with T2WI, DWI, and the combined sets
were 91.4%, 84.5%, and 97.8%, respectively. There
was a significant difference in characterization accu-
racy of the malignant lesions between T2WI and DWI
sets, between T2WI and the combined sets, and
between DWI and the combined sets (T2WI vs. DWI:
adjusted OR, 0.401, P ¼ 0.011. T2WI vs. the combined
interpretation: adjusted OR, 5.800, P ¼ 0.004. DWI vs.
the combined: adjusted OR, 14.469, P < 0.001).
Table 2
Correctly Characterized FLLs With Each Sequence in All, Benign, Malignant Lesions
Sequence All lesions (n ¼ 269) Benign lesions (n ¼ 153) Malignant lesions (n ¼ 116)
DWI 73.2 (197/269) 64.7 (99/153) 84.5 (98/116)
T2WI 68.0 (183/269) 50.3 (77/153) 91.4 (106/116)
Combined 80.3 (216/269) 67.0 (102.5/153) 97.8 (113.5/116)
P value DWI vs. T2WI 0.058 <0.001 0.011
DWI vs. Combined 0.001 0.504 <0.001
T2WI vs. Combined <0.001 <0.001 0.004
Data are averaged for two independent observers. Unless otherwise indicated, numbers are percentages, with raw data in parentheses.
DWI: diffusion-weighted imaging; T2WI: T2-weighted imaging; Combined: DWIþT2WI.
Table 3
Correctly Characterized FLLs With Each Sequence by the Two Readers in All, Benign, Malignant Lesions
Sequence All lesions (n ¼ 269) Benign lesions (n ¼ 153) Malignant lesions (n ¼ 116)
Reader 1 DWI 73.6 (198/269) 64.1 (98/153) 86.2 (100/116)
T2WI 69.5 (187/269) 50.3 (77/153) 94.8 (110/116)
Combined 80.3 (216/269) 65.4 (100/153) 100.0 (116/116)
Reader 2 DWI 72.9 (196/269) 65.4 (100/153) 82.8 (96/116)
T2WI 66.5 (179/269) 50.3 (77/153) 87.9 (102/116)
Combined 80.3 (216/269) 68.6 (105/153) 95.7 (111/116)
Unless otherwise indicated, numbers are percentages, with raw data in parentheses.
DWI: diffusion-weighted imaging; T2WI: T2-weighted imaging; Combined: DWIþT2WI.
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Reader agreement for the visual discrimination
between benign and malignant lesions using T2WI
alone, DWI alone, and the combined interpretation
was excellent, given the k values of 0.921 (95% confi-
dence interval [CI]: 0.881–0.961), 0.923 (95% CI:
0.882–0.962), 0.932 (95% CI: 0.892–0.964),
respectively.
Misclassified Lesions
The 18 benign lesions misjudged as malignant by both
readers at T2WI included eight FNHs (14.8%, 8/54)
(Fig. 2), seven adenomas (41.2%, 7/17), one hemangi-
oma (1.96%, 1/51), one (100%, 1/1) abscess, and one
pseudotumor (50%, 1/2).
Figure 2. Multiple FNHs in a 63-year-old man. a: Transverse fat saturated T2-weighted image. b: Transverse DWIs obtained
with a b-value of 50 s/mm2, and (c) ADC map (d) dynamic contrast-enhanced MR images with Gd-EOB-DTPA in the arterial
phase (e) and in the hepatobiliary phase. On fat-saturated T2-weighted images, three FNHs with moderately high signal are
shown in segments VII–VIII. The margins of the three lesions are irregular and the central parts of the two larger lesions
(arrows) show markedly high signal intensity on the T2-weighted images. The two FNHs were misjudged as malignant lesions
(a score of 3) by both readers because they mimicked metastatic lesions with central necrosis. The three FNHs also display
moderately high signal intensity at DWI obtained with a b-value of 50 s/mm2. On the corresponding ADC map, the three
FNHs demonstrate clear hyperintensity with relatively high ADCs (1.48  103mm2/s) compared to surrounding liver paren-
chyma, and the lesions were correctly judged as benign (a score of 1) by both readers. The three FNHs demonstrate intense
arterial enhancement and remain hyperintense in the hepatobiliary phase, which are typical features of FNH. The central
hypointense areas (arrows) within the masses are shown on the hepatobiliary phase image, which corresponds to central
vascular scars.
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The four benign lesions misjudged as malignant by
both readers at DWI included two (3.92%, 2/51)
hemangiomas, one (5.88%, 1/17) adenoma, and one
(100%, 1/1) abscess.
The five malignant lesions misjudged as benign by
both readers at DWI included four lymphomas (80%,
4/5) and one complete necrotic metastasis (2.94%,
1/34). The four lymphomas and one metastasis
appeared hyperintense to surrounding liver paren-
chyma on the ADC map due to uncommonly high ADCs
(1.12  103mm2/s). The four HCCs (7.27%, 4/55)
were miscategorized as benign at DWI by reader 1.
Meanwhile, all false-negative cases of malignant
lesions were judged as indeterminate and there were
no cases of them misjudged as benign at T2WI.
DISCUSSION
Unenhanced MR sequences are essential in the char-
acterization of FLLs, even in an MR liver protocol that
already included a dynamic contrast-enhanced
sequence. Both T2WI and DWI play major roles for
Figure 3. Adenoma and FNH in a 31-year-old woman. a: Transverse T2-weighted image. b,c: Transverse DWIs obtained with
b-values of 50 (b) s/mm2 and 800 (c) s/mm2, (d) ADC map, and (e) hepatobiliary phase MR image with Gd-EOB-DTPA. At
T2WI, the adenoma is isointense and the FNH with tiny scar (arrowhead) is mildly hyperintense relative to the surrounding
liver parenchyma. Both lesions were judged as indeterminate (a score of 2 was assigned) by both readers. On DWIs the ade-
noma (asterisk) demonstrates slightly hypointensity relative to the surrounding liver parenchyma, while FNH (arrow) displays
mild hyperintensity at a b-value of 50 s/mm2 and the signal disappears at a b-value of 800 s/mm2. On the ADC map, the ad-
enoma is isointense and the FNH (arrow) is mildly hyperintense relative to the surrounding liver parenchyma. On the basis of
the DWIs the adenoma was classified as indeterminate (a score of 2) and the FNH was correctly judged as benign (a score of
1) by the two readers. On hepatobiliary phase MR images with Gd-EOB-DTPA, the adenoma (asterisk) is characteristically
hypointense (which may be explained by the absence of biliary tree development within this tumor) and the FNH (arrow) is
mildly hyperintense relative to the surrounding liver parenchyma.
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that purpose in a clinical setting (9–11,19). Although
the roles of T2WI and DWI may be similar in the char-
acterization of FLLs, there are limited data on the
comparison between T2WI and DWI, and most previ-
ous studies mainly included cysts and hemangiomas
as benign lesions (11,19). Advantages and disadvan-
tages of each sequence in the characterization of FLLs
have not been fully investigated yet.
Our study showed that the combination of T2WI
and DWI could provide significantly higher accuracy
in discriminating benign from malignant FLLs than
T2WI alone and DWI alone.
In agreement with previous reports (11,19), we also
found that almost all cystic benign lesions were cor-
rectly characterized with both T2WI and DWI, without
any significant differences between the two sequen-
ces. Among cystic benign lesions, one hemangioma at
T2WI and two hemangiomas at DWI were mischarac-
terized as malignant lesions. Theses lesions showed
decreased signal on T2WI and the ADC map, suggest-
ing a hyalinized hemangioma. As previously reported
(32), hyalinized hemangioma changes its radiologic
features due to extensive fibrous tissue within the
tumor and obliteration of their vascular channels,
and it sometimes may be misdiagnosed as malignant
tumor. Thus, it should be mentioned that hyalinized
hemangioma could show only slight high intensity on
T2WI and decreasing its ADC value appearing isoin-
tense or slightly hypointense on ADC map. Regarding
the discrimination between solid benign and malig-
nant lesions, we found that the diagnostic perform-
ance of DWI in the differentiation between solid
benign tumors (adenoma and FNH) from malignant
FLLs to be better than that of T2WI, although its util-
ity was still limited in adenoma cases (Fig. 3). Particu-
larly in FNH cases, the diagnostic ability with DWI
was superior to that with T2WI. Eight FNHs (14.8%,
8/54) were mischaracterized as malignant lesion on
T2WI, while no case was observed like this on DWI.
The exact reason why the DWI indicated better latent
ability for the differentiation is unclear, despite the
solid benign tumors showing higher cellularity. We
speculate that hypervascularization of solid benign
tumors could alter diffusion, as some HCCs also show
a false increase in ADC values (33). Moreover, com-
pared to malignant lesions, cellular density of benign
solid tumors may basically be lower because the
growth speed of malignant tumors is rapid and they
grow continuously, while that of benign solid tumors
is slower and usually their sizes remain almost
unchanged. Additionally, in FNH cases, the presence
of a central vascular scar may also be another reason
for the better results of the differentiation. Among 19
FNHs, which were identified by a central vascular
scar within the tumors on DWI with each b-value and
ADC maps, seven (36.8%) were correctly judged as
benign using this additional information, although
this additional value may be limited for the diagnosis
of small FNH (particular less than 3 cm), in which the
central scar is possibly absent.
Basically, all image sequences were more accurate
in the characterization of malignant FLLs than of
benign FLLs (P < 0.001). In particular, the accuracies
were almost complete for the diagnosis of metastasis
and CCC. These malignant tumors usually show typi-
cal malignant features, although metastasis with large
cystic necrosis, which could show increasing signal
and ADC value, may appear as benign tumors, as pre-
vious researchers mentioned (34). Meanwhile, the
accuracy with DWI for the diagnosis of HCC was infe-
rior to that with T2WI. The four HCCs (7.27%, 4/55)
were miscategorized as benign at DWI by reader 1,
while all false-negative cases of malignant lesions
were judged as indeterminate and there were no cases
of them misjudged as benign at T2WI. As some inves-
tigators indicated (35,36), the histological grade of
HCCs could affect signal intensity of the tumors
because DWI is more closely related to the histological
changes of hepatocellular lesions than T2WI. More
than 90% of moderately or poorly differentiated HCCs
appear hyperintense; however, 67% of well-differenti-
ated HCCs appear isointense on DWI (36). Moreover,
histological changes of background liver parenchyma,
such as fibrosis, fibrous septa, or regenerative nod-
ules could also change the lesion-to-liver contrast on
DWI. In some cases that may lead to difficulties of
interpretation on ADC maps because of heterogeneity
of background liver parenchyma. These factors seem
to be attributed to the loss of diagnostic confidence
with DWI compared to T2WI in HCC cases. All four
lymphoma were misdiagnosed as benign on DWI due
to having unusually higher ADC values, although they
were correctly judged as malignant on T2WI.
Because of these complementary effects of T2WI and
DWI, our study indicates that combined interpretation
of them could provide significantly higher accuracy in
discriminating benign from malignant FLLs than each
single reading of T2WI and DWI. Therefore, these
sequences are essential together in the scanning proto-
cols of clinical practice and combined reading could
provide better ability in the characterization of FLLs.
This study has several limitations. First, the study
design was retrospective and we included patients
who had undergone MRI for diagnostic purposes, as
part of routine clinical care. Although this may have
introduced some bias, we believe that our results are
valid because we included a consecutive series of
patient during a relatively long period. Second, not all
FLLs could be diagnosed histopathologically. Never-
theless, careful consensus reading by experienced
abdominal radiologists and follow-up examinations
were used to establish a final diagnosis in these
cases. Third, in this study we evaluated diagnostic
ability with only visual assessment of each image
sequence and did not include it in ADC measure-
ments, although we also measured ADC values of all
FLLs because the point at issue was more focused.
Fourth, DWI and T2WI were not compared to con-
trast-enhanced MRI in this study. Basically, contrast-
enhanced MRI is superior to unenhanced MRI in the
characterization of FLLs. However, unenhanced MRI
such as T2WI and DWI could provide additional
important information, which may not be obtained
with contrast-enhanced MRI. Moreover, in those
patients with contraindications to contrast agents (eg,
patients having contrast agent allergy or impaired
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renal function), these sequences become crucial role
in the characterization of FLLs.
In conclusion, the characterization accuracy was sig-
nificantly higher in combined characterization by T2WI
and DWI as compared to either of these two imaging
modalities alone in all lesions and subgroups of benign
and malignant lesions. Regarding a comparison between
T2WI and DWI, the characterization accuracy was signifi-
cantly higher in DWI in the benign lesions but was signif-
icantly higher in T2WI in the malignant lesions.
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